Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy

By Reardon David A   Wen Patrick Y   Desjardins Annick   Batchelor Tracy T   Vredenburgh James J  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 4, 2008-04 ,pp. : 541-553

Informa Healthcare

Access to resources Recommend Favorite

VEGF blocking therapy in the treatment of cancer

By Glade-Bender Julia   Kandel Jessica J   Yamashiro Darrell J  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 263-276

Informa Healthcare

Access to resources Recommend Favorite

Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration

By Costagliola Ciro   Agnifili Luca   Arcidiacono Barbara   Duse Sarah   Fasanella Vincenzo   Mastropasqua Rodolfo   Verolino Marco   Semeraro Francesco  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 10, 2012-10 ,pp. : 1299-1313

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab in the treatment of colorectal cancer

By Mulcahy Mary F   Benson III Al B  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 7, 2005-07 ,pp. : 997-1005

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab in the treatment of hereditary hemorrhagic telangiectasia

By Kanellopoulou Theoni  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1315-1323

Informa Healthcare

Access to resources Recommend Favorite